Semaglutide Semaglutide (Ozempic, Wegowy) is another GLP-1 receptor agonist that has a similar mechanism of action as liraglutide, and the FDA also approves it for the same indications
Called Triple G, retatrutide acts on three hormone receptors: GLP-1, GIP, and glucagon
Functional study revealed that application of GLP-1R antagonist into the VTA attenuates peripheral application of exendin-4-induced anorectic effects (Mietlicki-Baase et al., 2013)
If you miss a dose, take it as soon as you remember unless its almost time for your next dose
Suppress Appetite: Gain control over cravings and reduce caloric intake
According to Ozempics prescribing information, providers and patients should consider the developmental and health advantages of breastfeeding, the mothers clinical need for Semaglutide, and any potential adverse events to the infant during treatment